J
John Commins
Researcher at University of Utah
Publications - 15
Citations - 1483
John Commins is an academic researcher from University of Utah. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 9, co-authored 13 publications receiving 1178 citations.
Papers
More filters
Journal ArticleDOI
Selection criteria for lung-cancer screening.
Martin C. Tammemägi,Hormuzd A. Katki,William G. Hocking,Timothy R. Church,Neil E. Caporaso,Paul A. Kvale,Anil K. Chaturvedi,Gerard A. Silvestri,Thomas L. Riley,John Commins,Christine D. Berg +10 more
TL;DR: The use of the PLCO(M2012) model was more sensitive than the NLST criteria for lung-cancer detection and compared the accuracy of PLCo(M 2012) criteria withNLST criteria to detect lung cancer.
Journal ArticleDOI
Lung Cancer Risk Prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Models and Validation
C. Martin Tammemagi,Paul F. Pinsky,Neil E. Caporaso,Paul A. Kvale,William G. Hocking,Timothy R. Church,Thomas L. Riley,John Commins,Martin M. Oken,Christine D. Berg,Philip C. Prorok +10 more
TL;DR: The PLCO lung cancer risk models demonstrate high discrimination and calibration, and had high discrimination in women, men, whites, and nonwhites.
Journal ArticleDOI
Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
Martin C. Tammemägi,Timothy R. Church,William G. Hocking,Gerard A. Silvestri,Paul A. Kvale,Thomas L. Riley,John Commins,Christine D. Berg +7 more
TL;DR: Martin Tammemägi and colleagues evaluate which risk groups of individuals, including nonsmokers and high-risk individuals from 65 to 80 years of age, should be screened for lung cancer using computed tomography.
Journal ArticleDOI
Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
William G. Hocking,Ping Hu,Martin M. Oken,Stephen D. Winslow,Paul A. Kvale,Philip C. Prorok,Lawrence R. Ragard,John Commins,David A. Lynch,Gerald L. Andriole,Saundra S. Buys,Mona N. Fouad,Carl R. Fuhrman,Claudine Isaacs,Lance A. Yokochi,Thomas L. Riley,Paul F. Pinsky,John K. Gohagan,Christine D. Berg +18 more
TL;DR: The P LCO Cancer Screening Trial demonstrated the ability to recruit, retain, and screen a large population over multiple years at multiple centers, but a conclusion on the effectiveness of CXR screening must await final PLCO results, which are anticipated at the end of 2015.
Journal ArticleDOI
Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
Martin C. Tammemägi,Kevin ten Haaf,Iakovos Toumazis,Chung Yin Kong,Summer S. Han,Jihyoun Jeon,John Commins,Thomas Riley,Rafael Meza +8 more
TL;DR: A model incorporating a validated lung cancer risk prediction model, the PLCOm2012 model, with National Lung Screening Trial results (PLCO2012results) predicted future lung cancer significantly better than a model excluding results.